Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis

Journal article

Peer reviewed

Paul Chervinsky, Thomas B. Casale, Robert G. Townley, Ita Tripathy, Simon Hedgecock, Angel Fowler-Taylor, Henry Shen and Howard Fox

Annals of Allergy, Asthma, & Immunology, Vol.91(2), pp.160-167

08/2003

Metrics

6 Record Views

Title: Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
Creators: Paul Chervinsky (Author)
Thomas B. Casale (Author) - Creighton University
Robert G. Townley (Author) - Creighton University
Ita Tripathy (Author)
Simon Hedgecock (Author)
Angel Fowler-Taylor (Author)
Henry Shen (Author)
Howard Fox (Author)
Publication Details: Annals of Allergy, Asthma, & Immunology, Vol.91(2), pp.160-167
Number of pages: 160-167
Identifiers: 991005931748002656
Academic Unit: School of Medicine; Allergy-Immunology; Endocrine
Resource Type: Journal article